EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Neuro-oncological superiority of supratotal resection in lower-grade gliomas

Alberto L Gallotti iD, Marco Rossi iD, Marco Conti Nibali, Tommaso Sciortino, Lorenzo G Gay, Guglielmo Puglisi, Antonella Leonetti, Francesco Bruno iD, Roberta Rudà iD, Riccardo Soffietti iD, Gabriella Cerri, Lorenzo Bello

Neuro-Oncology · 21.06.2025 · 27 (5) · 1270-1284

DOI: 10.1093/neuonc/noae264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 07.12.2024. Verfasst von Alberto L Gallotti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milano, Italy. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Neurosurgical Procedures, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Associazione Italiana Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Supratotal-resection (SpTR) is a promising surgical strategy in lower-grade gliomas (LGGs). SpTR assessment, feasibility and distinctive features, as well as clinical benefit at first and second surgery and on overall survival must be better characterized. The critical percentage of resection exceeding FLAIR margins to obtain clinical benefit and its impact on long-term functional performance are also undefined.

Methods

Included were 704 patients with primary and 439 with recurrent LGGs seen between 2010 and 2019, who underwent resection with brain-mapping technique (BMT) aimed at achieving a SpTR without any “a-priori” selection. Extent-of-resection, evaluated on 3D-FLAIR-MR and categorized according to residual tumor and cavity volume, was associated with progression-free survival (PFS) and malignant(M)PFS at first and second surgery and overall survival by univariate, multivariate, and propensity-score analysis. Functional performance was assessed by neuropsychological (NPS) evaluation.

Results

SpTR evaluation requires volumetric assessment enhanced by brain deformation measurement in parietal tumors; SpTR rate accounts on average for 50.2% and 35.7% at first and second surgery is higher in grade-2, frontal, and temporal locations (at expenses of total resection [TR]). Compared to TR, SpTR reduces and postpones first and second recurrences in all molecular subtypes and grades, delays MPFS without difference in rate, and prolongs overall survival (OS). A degree of SpTR > 120% associates with the lowest recurrence risk. SpTR associates with the best NPS longitudinal course.

Conclusions

This study supports the feasibility of SpTR in LGGs, its benefit at first and second surgery regardless of molecular subtypes, and on OS, significantly reducing recurrence when SpTR > 120%; SpTR also associates with the best patients’ functional outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsNeurosurgical ProceduresNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedNeoplasm GradingAdultSurvival RateAgedFollow-Up StudiesPrognosisYoung AdultRetrospective StudiesMagnetic Resonance ImagingAdolescentBrain Mapping

Stichwörter der Autor:innen

lower-grade gliomasneuropsychological evaluationoverall survivalrecurrencesupratotal resection

Autor:innen und Institutionen

  • Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milano, Italy.
  • Neurosurgery Unit, IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.
  • Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milano, Italy.
  • Division of Neuro-Oncology, Department of Neuroscience, Università degli Studi di Torino, Torino, Italy.

ORCID-Profile: Alberto L Gallotti, Marco Rossi, Francesco Bruno, Roberta Rudà, Riccardo Soffietti

Förderung

  • Associazione Italiana Ricerca sul Cancro

Zitieren

APA

Gallotti, A. L., Rossi, M., Conti Nibali, M., Sciortino, T., Gay, L. G., Puglisi, G., Leonetti, A., Bruno, F., Rudà, R., Soffietti, R., Cerri, G., & Bello, L. (2025). Neuro-oncological superiority of supratotal resection in lower-grade gliomas. Neuro-Oncology, 27(5), 1270-1284. https://doi.org/10.1093/neuonc/noae264

Vancouver

Gallotti AL, Rossi M, Conti Nibali M, Sciortino T, Gay LG, Puglisi G, et al. Neuro-oncological superiority of supratotal resection in lower-grade gliomas. Neuro-Oncology. 2025;27(5):1270-1284. doi:10.1093/neuonc/noae264

BibTeX
@article{Gallotti2025,
  author = {Gallotti, Alberto L and Rossi, Marco and Conti Nibali, Marco and Sciortino, Tommaso and Gay, Lorenzo G and Puglisi, Guglielmo and Leonetti, Antonella and Bruno, Francesco and Rudà, Roberta and Soffietti, Riccardo and Cerri, Gabriella and Bello, Lorenzo},
  title = {Neuro-oncological superiority of supratotal resection in lower-grade gliomas},
  journal = {Neuro-Oncology},
  year = {2025},
  volume = {27},
  number = {5},
  pages = {1270--1284},
  doi = {10.1093/neuonc/noae264}
}
Kostenlos starten →